Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01968135 · ClinicalTrials.gov registry record · Phase 2
Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study
A Phase 2 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT01968135 is a Phase 2 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 32 participants.
The verdict
NCT01968135, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
The specific aims are to determine if more women using Etonogestrel (ENG) contraceptive implants who report a bleeding-spotting episode of at least seven days will stop bleeding within 3 days of beginning a 14-day course of combined oral hormonal steroids, as compared to women receiving 14 days of placebo.
Interventions
- DRUG Combined Oral Contraceptive Pill
- DRUG Placebo Sugar Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01968135
The ClinicalTrials.gov registry entry for NCT01968135 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Combined Oral Contraceptive Pill is the first listed.
NCT01968135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01968135 about?
NCT01968135 is a clinical study titled "Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study". The specific aims are to determine if more women using Etonogestrel (ENG) contraceptive implants who report a bleeding-spotting episode of at least seven days will stop bleeding within 3 days of beginning a 14-day course of combined oral hormonal steroids, as compared to women receiving 14 days of p...
What is the current status of trial NCT01968135?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2013-10. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01968135?
The interventions under investigation include: Combined Oral Contraceptive Pill (DRUG), Placebo Sugar Pill (DRUG).
Who is sponsoring clinical trial NCT01968135?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.